Gyre Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $13.2M | $40.3M | $34.8M |
| Jun 2022 | $4.3M | $83.4M | $75.4M |
| Sep 2022 | $1.6M | $31.0M | $23.1M |
| Dec 2022 | $12.5M | $84.8M | $25.2M |
| Mar 2023 | $11.4M | $18.8M | $8.1M |
| Jun 2023 | $7.4M | $12.4M | $6.9M |
| Sep 2023 | $6.4M | $10.0M | $2.2M |
| Dec 2023 | $38.1M | $116.5M | $33.5M |
| Mar 2024 | $33.2M | $122.0M | $29.8M |
| Jun 2024 | $27.6M | $120.9M | $16.1M |
| Sep 2024 | $26.8M | $125.2M | $15.9M |
| Dec 2024 | $27.0M | $125.4M | $11.8M |
| Mar 2025 | $25.5M | $129.8M | $15.0M |
| Jun 2025 | $23.2M | $152.6M | $36.5M |
| Sep 2025 | $22.0M | $159.4M | $40.4M |
| Dec 2025 | $31.4M | $219.8M | $49.2M |
| Mar 2026 | $25.0M | $162.0M | $37.5M |
| Jun 2026 | $34.3M | $199.3M | $43.3M |